🇺🇸 FDA
Patent

US 11826429

Pharmaceutical composition comprising brinzolamide

granted A61KA61K31/542A61K47/26

Quick answer

US patent 11826429 (Pharmaceutical composition comprising brinzolamide) held by SENTISS PHARMA PRIVATE LIMITED expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SENTISS PHARMA PRIVATE LIMITED
Grant date
Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/542, A61K47/26, A61K47/32, A61K47/34